Categories: Economy

S&P keeps India’s economic growth forecast unchanged at 6% for FY24

S&P Global Ratings has maintained its earlier projection for India’s economic growth rate at 6% in the fiscal year starting from April 1, with a further increase to 6.9% in the following year. In its latest quarterly economic update for Asia-Pacific, S&P predicted that the inflation rate would decline to 5% during the 2023-24 fiscal year, down from the current financial year’s 6.8%.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

S&P: India’s gross domestic product (GDP) growth:

The report stated that India’s gross domestic product (GDP) is likely to grow by 7% in the present financial year, which ends on March 31, 2023, before slowing down to 6% in the subsequent fiscal year 2023-24.

The report also highlighted that India is leading with an average growth rate of 7% during 2024-2026.

S&P: India’s Steady Growth Rate, Exports and more:

The rating agency has projected that GDP will increase to 6.9% in the next two financial years, 2024-25 and 2025-26, with a further rise to 7.1% in 2026-27.

The report stated that India’s economy has traditionally been driven by domestic demand, but has become more responsive to the global economic cycle in recent times, partly due to the increased exports of commodities.

As a result, the year-on-year GDP growth rate slowed to 4.4% during the fourth quarter (October-December 2022), according to the rating agency.

You may also read these:

Find More News on Economy Here

Piyush Shukla

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

4 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

5 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

5 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

6 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

7 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

7 hours ago